v3.25.4
FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Industries and Geographical Locations Comprising Greater than 10% of Portfolio Fair Value (Details) - USD ($)
6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Jun. 30, 2025
Concentration Risk [Line Items]      
Cost $ 71,950,376 [1]   $ 88,404,806 [2]
Fair Value 63,918,767 [3]   85,016,596 [4]
Healthcare & Pharmaceuticals      
Concentration Risk [Line Items]      
Cost 23,261,465   22,729,225
Fair Value $ 23,923,428   22,902,129
Healthcare & Pharmaceuticals | Investments at Fair Value | Industry Concentration Risk      
Concentration Risk [Line Items]      
% of Portfolio 37.00% 27.00%  
All Other Industries      
Concentration Risk [Line Items]      
Cost $ 48,688,911   65,675,581
Fair Value $ 39,995,339   $ 62,114,467
All Other Industries | Investments at Fair Value | Industry Concentration Risk      
Concentration Risk [Line Items]      
% of Portfolio 63.00% 73.00%  
Total | Investments at Fair Value | Industry Concentration Risk      
Concentration Risk [Line Items]      
% of Portfolio 100.00% 100.00%  
[1] See Note 6 for a discussion of the tax cost of the portfolio.
[2] See Note 6 for a discussion of the tax cost of the portfolio.
[3] Fair value is determined by the Company’s Board of Directors (see Note 2).
[4] Fair value is determined by the Company’s Board of Directors (see Note 2).